QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NASDAQ:NARI

Inari Medical (NARI) Stock Forecast, Price & News

$60.33
-1.15 (-1.87%)
(As of 06/7/2023 ET)
Compare
Today's Range
$60.00
$62.38
50-Day Range
$58.97
$71.17
52-Week Range
$52.59
$86.94
Volume
740,497 shs
Average Volume
828,410 shs
Market Capitalization
$3.45 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$89.11

Inari Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
47.7% Upside
$89.11 Price Target
Short Interest
Bearish
7.03% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.49mentions of Inari Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$11.75 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.27) to $0.33 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.98 out of 5 stars

Medical Sector

523rd out of 981 stocks

Surgical & Medical Instruments Industry

51st out of 97 stocks


NARI stock logo

About Inari Medical (NASDAQ:NARI) Stock

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

NARI Stock News Headlines

Famous Wall Street Crash System Flashes RED
Hundreds of banks, hedge funds, and brokerages have paid $5,000 a month to access these alerts. Because when this system flashes on U.S. stocks, huge gains – and losses – can follow.
Famous Wall Street Crash System Flashes RED
Hundreds of banks, hedge funds, and brokerages have paid $5,000 a month to access these alerts. Because when this system flashes on U.S. stocks, huge gains – and losses – can follow.
BTIG Remains a Buy on Inari Medical (NARI)
What Wall Street expects from Inari Medical's earnings
See More Headlines

NARI Price History

NARI Company Calendar

Last Earnings
5/03/2023
Today
6/07/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NARI
Fax
N/A
Employees
1,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$89.11
High Stock Price Forecast
$105.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+46.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

Net Income
$-29,270,000.00
Pretax Margin
-5.87%

Debt

Sales & Book Value

Annual Sales
$383.47 million
Book Value
$7.77 per share

Miscellaneous

Free Float
49,339,000
Market Cap
$3.47 billion
Optionable
Not Optionable
Beta
1.12

Key Executives

  • Mr. William H. HoffmanMr. William H. Hoffman (Age 56)
    CEO, Pres & Director
    Comp: $1.35M
  • Mr. Mitchell C. HillMr. Mitchell C. Hill (Age 64)
    Chief Financial Officer
    Comp: $687.42k
  • Mr. Andrew J. HykesMr. Andrew J. Hykes (Age 50)
    Chief Operating Officer
    Comp: $750.84k
  • Dr. Thomas M. Tu M.D. (Age 50)
    Chief Medical Officer
    Comp: $752.29k
  • Ms. Janet Byk
    VP of Fin. & Accounting
  • Ms. Angela Ahmad
    Gen. Counsel & Sec.
  • Mr. Eric Khairy
    Sr. VP of Marketing
  • Mr. John R. Borrell (Age 56)
    Sr. VP of Sales
  • Ms. Dena Truelove
    VP of HR
  • Ms. Tara Dunn
    Sr. VP of Clinical Affairs & Market Devel.













NARI Stock - Frequently Asked Questions

Should I buy or sell Inari Medical stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NARI shares.
View NARI analyst ratings
or view top-rated stocks.

What is Inari Medical's stock price forecast for 2023?

8 Wall Street analysts have issued 1 year price targets for Inari Medical's stock. Their NARI share price forecasts range from $70.00 to $105.00. On average, they anticipate the company's share price to reach $89.11 in the next twelve months. This suggests a possible upside of 46.9% from the stock's current price.
View analysts price targets for NARI
or view top-rated stocks among Wall Street analysts.

How have NARI shares performed in 2023?

Inari Medical's stock was trading at $63.56 on January 1st, 2023. Since then, NARI shares have decreased by 4.6% and is now trading at $60.66.
View the best growth stocks for 2023 here
.

Are investors shorting Inari Medical?

Inari Medical saw a increase in short interest in May. As of May 15th, there was short interest totaling 3,370,000 shares, an increase of 25.7% from the April 30th total of 2,680,000 shares. Based on an average daily volume of 838,900 shares, the short-interest ratio is currently 4.0 days. Approximately 7.0% of the shares of the company are sold short.
View Inari Medical's Short Interest
.

When is Inari Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our NARI earnings forecast
.

How were Inari Medical's earnings last quarter?

Inari Medical, Inc. (NASDAQ:NARI) issued its earnings results on Wednesday, May, 3rd. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.19. The company had revenue of $116.17 million for the quarter, compared to analyst estimates of $110.30 million. Inari Medical had a negative trailing twelve-month return on equity of 6.78% and a negative net margin of 6.87%. Inari Medical's revenue was up 33.9% on a year-over-year basis. During the same period last year, the business earned ($0.06) earnings per share.

What guidance has Inari Medical issued on next quarter's earnings?

Inari Medical updated its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $478.00 million-$488.00 million, compared to the consensus revenue estimate of $476.10 million.

What other stocks do shareholders of Inari Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY).

When did Inari Medical IPO?

(NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers.

What is Inari Medical's stock symbol?

Inari Medical trades on the NASDAQ under the ticker symbol "NARI."

Who are Inari Medical's major shareholders?

Inari Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.89%), Wellington Management Group LLP (8.87%), Franklin Resources Inc. (4.89%), Price T Rowe Associates Inc. MD (3.26%), State Street Corp (2.90%) and Brown Advisory Inc. (2.29%). Insiders that own company stock include Andrew Hykes, Ansbert Gadicke, Donald B Milder, Gilde Healthcare Cooperatieve, Kirk G Nielsen, Mitch C Hill, Mitch C Hill, Presidio Management Group X Ll, Stanley Tang, Thomas Tu and William Hoffman.
View institutional ownership trends
.

How do I buy shares of Inari Medical?

Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inari Medical's stock price today?

One share of NARI stock can currently be purchased for approximately $60.66.

How much money does Inari Medical make?

Inari Medical (NASDAQ:NARI) has a market capitalization of $3.47 billion and generates $383.47 million in revenue each year. The company earns $-29,270,000.00 in net income (profit) each year or ($0.53) on an earnings per share basis.

How many employees does Inari Medical have?

The company employs 1,100 workers across the globe.

How can I contact Inari Medical?

Inari Medical's mailing address is 9 Parker Suite 100, Irvine CA, 92618. The official website for the company is www.inarimedical.com. The company can be reached via phone at 877-923-4747 or via email at ir@inarimedical.com.

This page (NASDAQ:NARI) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -